Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature
Open Access
- 27 December 2018
- journal article
- review article
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 2 (1) , 1-21
Abstract
To explore the existing evidence of the real-world implementation of patient-reported outcomes (PROs) in oncology clinical practice and address two aims: (1) summarize available evidence of PRO use in clinical practice using a framework based on the International Society for Quality of Life Research (ISOQOL) PRO Implementation Guide; and (2) describe reports of real-world, standardized PRO administration in oncology conducted outside of scope of a research study. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol was developed to guide the systematic literature review (SLR) that was conducted in MEDLINE and Embase databases. A two step search strategy was implemented including two searches based on previously completed reviews. Studies published from 2006 to 2017 were synthesized using a framework based on the ISOQOL PRO Implementation Guide. After screening 4427 abstracts, 36 studies met the eligibility criteria. Most elements of the ISOQOL PRO Implementation Guide were followed. Two notable exceptions were found: 1) providing PRO score interpretation guidelines (39% of studies); and 2) providing patient-management guidance for addressing issues identified by PROs (25% of studies). Of the 22 studies with an intervention component, 19 (86%) reported intervention effects on study outcomes. The European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30 (EORTC QLQ-C30) was the most commonly used PRO (n = 10, 28%); use of 38 other PRO measures was also reported. Only three studies (8%) reported real-world PRO implementation. Reports of real-world PRO implementation are limited. Reports from studies conducted in clinical settings suggest gaps in information on PRO score interpretation and the use of PRO results to inform patient management. Before the promise of practice-based PRO assessment in oncology can be truly realized, investigators need to advance the state-of-the-art of real-time PRO score interpretation as well as developing guidance on how to use PRO insights to drive clinically-meaningful patient-management strategies.Keywords
Funding Information
- Genentech
This publication has 87 references indexed in Scilit:
- A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic settingBMC Health Services Research, 2013
- Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom ScreeningJournal of Oncology Practice, 2012
- Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized TrialJournal of Clinical Oncology, 2011
- A technical solution to improving palliative and hospice careSupportive Care in Cancer, 2011
- Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trialEuropean Journal of Cancer, 2010
- Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trialJournal of the American Medical Informatics Association, 2010
- Acceptability of an Electronic Self-report Assessment Program for Patients With CancerCIN: Computers, Informatics, Nursing, 2008
- Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties InventoryBritish Journal of Cancer, 2007
- Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy ToxicitiesJournal of the American Medical Informatics Association, 2007
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993